Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Techne

57.09
+3.095.72%
Post-market: 57.090.00000.00%19:27 EDT
Volume:1.44M
Turnover:82.12M
Market Cap:8.95B
PE:124.11
High:57.43
Open:54.89
Low:54.31
Close:54.00
52wk High:80.95
52wk Low:46.01
Shares:156.77M
Float Shares:154.93M
Volume Ratio:0.93
T/O Rate:0.93%
Dividend:0.32
Dividend Rate:0.56%
EPS(TTM):0.4600
EPS(LYR):0.4660
ROE:3.68%
ROA:2.92%
PB:4.66
PE(LYR):122.52

Loading ...

Bio-Techne Corp Exec Says Co Anticipates Organic Growth Will Remain in a Low Single Digit Range Until the Current Headwinds Begin to Subside - Conf Call

THOMSON REUTERS
·
Aug 06

Bio-Techne Corp Exec Says Customers Are Actually Behaving More Conservative Than Even the Worst Case Scenario - Conf Call

THOMSON REUTERS
·
Aug 06

Bio-Techne beats quarterly estimates on strength in protein sciences unit

Reuters
·
Aug 06

Bio-Techne Q4 Adj. EPS $0.53 Beats $0.50 Estimate, Sales $316.964M Beat $316.004M Estimate

Benzinga
·
Aug 06

Bio-Techne Q4 Operating Expenses USD 222.672 Million

THOMSON REUTERS
·
Aug 06

BRIEF-Bio-Techne Announces Exosome Diagnostics Divestiture

Reuters
·
Aug 06

Bio-Techne Corporation Announces Divestiture of Exosome Diagnostics to Mdxhealth in Strategic Move

Reuters
·
Aug 06

Bio-Techne Corp - to Receive $5 Mln in Mdxh Stock Combined With Future Considerations

THOMSON REUTERS
·
Aug 06

Bio-Techne Corp - Under the Terms of Agreement, Bio-Techne Will Receive $5 Million in Mdxh Stock Combined With Future Considerations

THOMSON REUTERS
·
Aug 06

MDxHealth Reports 20% Increase in Q2 Revenue, Achieves Positive Adjusted EBITDA of $1.4 Million, and Reduces Net Loss by 36%

Reuters
·
Aug 06

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

GlobeNewswire
·
Aug 06

YSX TECH. CO. 2025 Total Revenue $71.5M, Up 22%

Benzinga
·
Aug 01

YSX TECH. CO., LTD Announces Financial Results for Fiscal Year 2025

GlobeNewswire
·
Aug 01

Baird Adjusts Price Target on Bio-Techne to $58 From $51

MT Newswires Live
·
Aug 01

Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jul 30

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jul 23

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jul 18

Bio-Techne Corporation to Announce Fourth Quarter and Fiscal 2025 Financial Results

Reuters
·
Jul 17

Bio-Techne and Spear Bio partner for ultrasensitive biomarker detection

TIPRANKS
·
Jul 15

Bio-Techne Corporation Announces Strategic Partnership with Spear Bio to Advance Biomarker Detection in Neurodegenerative Disease Research

Reuters
·
Jul 15